DIFMUNIZE
Live / Allowed — Notice of allowance issued (as of 20 Oct 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 27 May 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99848481
- Mark type
- Word mark
- Filed
- 27 May 2026
- Published for opposition
- 25 Aug 2026
- Attorney of record
- Yana Gorbach
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, respiratory, and viral diseases and disorders; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, hormonal disorders, skin disorders, arthritis, cancer, cachexia, hypertension, migraine, pain, stroke, obesity and diabetes; Pharmaceuticals, namely, anti-infectives; Medicated dermatological preparations and substances; Antifungal preparations; Smoking cessation preparations; Vaccines for human use
Owner
- Pfizer Inc., New York, NY, US
- Pfizer Inc., New York, NY, US
Prosecution history
- 20 Oct 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 25 Aug 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Aug 2026 — PUBLISHED FOR OPPOSITION
- 19 Aug 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 28 Jul 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 28 Jul 2026 — ASSIGNED TO EXAMINER
- 27 May 2026 — APPLICATION FILING RECEIPT MAILED
- 27 May 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 27 May 2026 — NEW APPLICATION ENTERED